Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lan Phuong Vu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
ACS Omega|January 17, 2022
Diketomorpholines: Synthetic Accessibility and UtilizationLan Phuong Vu, Michael Gütschow
Bioorganic Chemistry|February 24, 2022
Combinatorial assembly, traceless generation and in situ evaluation of inhibitors for therapeutically relevant serine proteasesLan Phuong Vu, Maria Zyulina, Alexandra Hingst, et al.
Vision Research|August 27, 2009
The temporal impulse response function during smooth pursuitJianliang Tong, Mahalakshmi Ramamurthy, Saumil S Patel, et al.
Vision Research|June 14, 2008
The temporal impulse response function in infantile nystagmusHarold E Bedell, Mahalakshmi Ramamurthy, Saumil S Patel, et al.
Chemical Communications (Cambridge, England)|January 24, 2019
PROTAC-mediated crosstalk between E3 ligasesChristian Steinebach, Hannes Kehm, Stefanie Lindner, et al.
Acta Pharmaceutica Sinica. B|May 27, 2024
Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kineticsRabea Voget, Julian Breidenbach, Tobias Claff, et al.
Journal of Medicinal Chemistry|September 14, 2023
Expanding the Structural Diversity at the Phenylene Core of Ligands for the von Hippel-Lindau E3 Ubiquitin Ligase: Development of Highly Potent Hypoxia-Inducible Factor-1α StabilizersLan Phuong Vu, Claudia J Diehl, Ryan Casement, et al.
Chemical Science|November 2, 2020
Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degradersChristian Steinebach, Yuen Lam Dora Ng, Izidor Sosič, et al.
Angewandte Chemie (International Ed. in English)|March 3, 2021
Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored InhibitorsJulian Breidenbach, Carina Lemke, Thanigaimalai Pillaiyar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
ACS Omega|January 17, 2022
Diketomorpholines: Synthetic Accessibility and UtilizationLan Phuong Vu, Michael Gütschow
Bioorganic Chemistry|February 24, 2022
Combinatorial assembly, traceless generation and in situ evaluation of inhibitors for therapeutically relevant serine proteasesLan Phuong Vu, Maria Zyulina, Alexandra Hingst, et al.
Vision Research|August 27, 2009
The temporal impulse response function during smooth pursuitJianliang Tong, Mahalakshmi Ramamurthy, Saumil S Patel, et al.
Vision Research|June 14, 2008
The temporal impulse response function in infantile nystagmusHarold E Bedell, Mahalakshmi Ramamurthy, Saumil S Patel, et al.
Chemical Communications (Cambridge, England)|January 24, 2019
PROTAC-mediated crosstalk between E3 ligasesChristian Steinebach, Hannes Kehm, Stefanie Lindner, et al.
Acta Pharmaceutica Sinica. B|May 27, 2024
Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kineticsRabea Voget, Julian Breidenbach, Tobias Claff, et al.
Journal of Medicinal Chemistry|September 14, 2023
Expanding the Structural Diversity at the Phenylene Core of Ligands for the von Hippel-Lindau E3 Ubiquitin Ligase: Development of Highly Potent Hypoxia-Inducible Factor-1α StabilizersLan Phuong Vu, Claudia J Diehl, Ryan Casement, et al.
Chemical Science|November 2, 2020
Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degradersChristian Steinebach, Yuen Lam Dora Ng, Izidor Sosič, et al.
Angewandte Chemie (International Ed. in English)|March 3, 2021
Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored InhibitorsJulian Breidenbach, Carina Lemke, Thanigaimalai Pillaiyar, et al.
Pageof 1